NEW ORLEANS & WASHINGTON--(BUSINESS WIRE)--RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time.
“It’s common for concussion patients to be in denial about their condition,” said Dr. Deann Fitzgerald, a prominent neuro optometrist who works with amateur and professional athletes of all ages and levels. “By now having this kind of report, based on specific eye-tracking data, we can literally show patients the hard evidence that they have a serious condition and more people will be able to get the treatment they need.”
RightEye Neuro Vision is an eye-tracked, digital eye test based on the smooth pursuit protocol, which is a leading manual concussion test used across the country by physicians to determine if a person’s eyes are able to closely follow a moving object. RightEye has taken this very subjective manual examination that requires observation of the patient’s eyes and has created a 15-second test that is objective, repeatable and comparable over time, and lets health care providers discover more about an individual’s health.
“We are extremely excited about the value RightEye Neuro Vision will bring to the entire healthcare industry because it has the potential to improve overall patient care for so many people,” said Adam Gross, CEO and co-founder of RightEye. “By using the most advanced eye tracking technology available, RightEye has developed better, faster, cheaper solutions that provide not only better vision care but enable better health care for everyone.”
Using RightEye Neuro Vision is simple and easy. The patient, while sitting in front of a computer that has a small eye tracking bar attached at the bottom of the screen, simply watches a circular digital animation for 15 seconds. Immediately following the test, the system automatically emails a report to the health care provider and patient that shows the eye-tracked digitization of the results and associated metrics.
RightEye Neuro Vision is delivered in a portable, sleek hardware package with a simple web-based software interface. The product can be licensed at variable rates from $595 to $2,000 per month depending on enterprise size. AAO event attendees will receive a special offer through Oct. 9 of an up to 50 percent discount for a six-month agreement with unlimited use for $495/month. To order, go to http://www.righteye.com/get-started and type “Academy Offer” in the message.
AAO attendees will have a chance to try out the RightEye Neuro Vision test firsthand during the show. The Academy of Optometry event boasts a diverse array of groundbreaking research in optometry, vision science and relevant education on the latest practices in eye care.
RightEye LLC is a health technology company using eye tracking to revolutionize vision performance and patient care. By following a science-based, metric-driven methodology, RightEye can help you improve how you see, how you feel and how you perform. In less than two-minutes, RightEye’s patented technology measures visual skills and provides critical insights into your health. RightEye also creates eye-tracking-based vision therapy solutions to help you achieve your Maximum Vision Performance. Achieve your MVP today — with RightEye. For more information, visit www.RightEye.com or follow us on Twitter or LinkedIn.